As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

While the ‘official’ flu season may still be a month or two away, reports indicate a rise in respiratory illnesses like the ...

Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease: New York Wednesday, April 2, 2025, 09:00 H ...

Pfizer’s respiratory syncytial virus (RSV) vaccine has been approved by the European Commission (EC) to prevent RSV-associated lower respiratory tract disease (LRTD) in individuals aged 18 to 59 years ...

The authors assessed the patient characteristics associated with RSV vaccination among older adults hospitalized during the ...

CEO Backer Marianne De sold 79,712 shares of Vir Biotechnology stock in a transaction that occurred on Thursday, April 3rd. The shares were sold at an average price of $5.95, for a total value of $474 ...

How should continental vaccine manufacturers handle complex dynamics of supply and demand? ANALYSIS | The African Union has ...

Milwaukee-area health departments planned to use the funding for a neighborhood nursing program, wastewater surveillance and ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

Learn more about whether Moderna, Inc. or Twist Bioscience Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Planet Classroom, the global youth-driven media network, unveils an extraordinary selection of films for April 2025, featuring trailblazing innovations in AI, climate action, classical music, and ...